Late-onset familial amyloid-polyneuropathy (FAP) Val30Met without family history

Clinical Medicine and Research

Volumn 6, Issue 2, 2008, Pages 80-82

  Rudolph, Thomas ^a   Kurz, Martin Wilhelm ^a,b   Farbu, Elisabeth ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

DNA sequencing; Familial amyloid polyneuropathy; Nerve biopsy; TR gene; Val30Met mutation

Indexed keywords

AMYLOID PROTEIN; DNA; METHIONINE; MONOCLONAL ANTIBODY; PREALBUMIN; REPAGLINIDE; VALINE; AMYLOID; AMYLOID PREALBUMIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; CLINICAL EXAMINATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DNA SEQUENCE; ELECTROMYOGRAPHY; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPESTHESIA; IMMUNOHISTOCHEMISTRY; MALE; NERVE BIOPSY; NERVE CONDUCTION; PENETRANCE; SENSORIMOTOR NEUROPATHY; SYMPTOM; AMINO ACID SUBSTITUTION; DOMINANT GENE; GENETICS; HETEROZYGOTE; MUTATION; ONSET AGE;

AGE OF ONSET; AGED; AMINO ACID SUBSTITUTION; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; GENES, DOMINANT; HETEROZYGOTE; HUMANS; MALE; MUTATION; PREALBUMIN;

EID: 58149175982     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.2008.794     Document Type: Article

References (13)

1. Saraiva MJ. Cellular consequences of transthyretin deposition. Amyloid 2003;10(suppl 1):13-16.
2. Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54-69.
3. Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G; Study Group for Hereditary Neuropathy in Japan. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs. late-onset form. Arch Neurol 2002; 59:1771-1776.
4. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995; 60:512-521.
5. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288-294.
6. Soares ML, Coelho T, Sousa A, Batalov S, Conceição I, Sales-Lu's ML, Ritchie MD, Williams SM, Nievergelt CM, Schork NJ, Saraiva MJ, Buxbaum JN. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet 2005;14:543-553.
7. Suhr O. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid 2003;10(suppl 1):77-83.
8. Coelho T, Sousa A, Lourenco E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994;31:293-299.
9. Yazaki M, Yamashita T, Kincaid JC, Scott JR, Auger RG, Dyck PJ, Benson MD. Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25. Muscle Nerve 2002;25:244-250.
10. Almeida MR, Aoyama-Oishi N, Sakaki Y, Holmgren G, Ulf D, Ferlini A, Salvi F, Munar-Oués M, Benson MD, Skinner M, Costa PP, Saraiva MJ. Haplotype analysis of common transthyretin mutations. Hum Genet 1995;96:350-354.
11. Conceição I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 2007;35:116-118.
12. Lindqvist P, Olofsson BO, Backman C, Suhr O, Waldenström A. Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr 2006;7:22-30.
13. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999;10:1951-1962.